Real-World Impact of Adherence to Inhaled Corticosteroid/Long-Acting Beta-Agonists on Asthma Outcomes in the US
Real-World Impact of Adherence to Inhaled Corticosteroid/Long-Acting Beta-Agonists on Asthma Outcomes in the US is a paper indexed in ScholarIQ from OpenAlex.
How many citations does Real-World Impact of Adherence to Inhaled Corticosteroid/Long-Acting Beta-Agonists on Asthma Outcomes in the US have?
Real-World Impact of Adherence to Inhaled Corticosteroid/Long-Acting Beta-Agonists on Asthma Outcomes in the US has 0 citations in the OpenAlex counts ScholarIQ stores.
When was Real-World Impact of Adherence to Inhaled Corticosteroid/Long-Acting Beta-Agonists on Asthma Outcomes in the US published?
Real-World Impact of Adherence to Inhaled Corticosteroid/Long-Acting Beta-Agonists on Asthma Outcomes in the US has 2021 year in the ScholarIQ index.
What is the open-access status of Real-World Impact of Adherence to Inhaled Corticosteroid/Long-Acting Beta-Agonists on Asthma Outcomes in the US?
Real-World Impact of Adherence to Inhaled Corticosteroid/Long-Acting Beta-Agonists on Asthma Outcomes in the US has gold oa status in the ScholarIQ index.
What is the DOI of Real-World Impact of Adherence to Inhaled Corticosteroid/Long-Acting Beta-Agonists on Asthma Outcomes in the US?
The DOI for Real-World Impact of Adherence to Inhaled Corticosteroid/Long-Acting Beta-Agonists on Asthma Outcomes in the US is on the source record.
What is the OpenAlex record for Real-World Impact of Adherence to Inhaled Corticosteroid/Long-Acting Beta-Agonists on Asthma Outcomes in the US?
The OpenAlex for Real-World Impact of Adherence to Inhaled Corticosteroid/Long-Acting Beta-Agonists on Asthma Outcomes in the US is on the source record.